The transdermal transport of pharmaceuticals possesses various advantageous properties over conventional drug administration techniques such as oral delivery and hypodermic injections. However, the stratum corneum persists as the main barrier, which impedes percutaneous transport. The ultrasound-based transdermal delivery of therapeutics is one of the techniques that are being investigated to overcome this obstacle. This review outlines the background information pertaining to sonophoresis and then discusses the individual sections of sonophoretic research. These areas include the sonophoretic application of various drugs, dual-frequency sonophoresis, synergistic combinations of transdermal drug delivery techniques, and the use of nanosized carriers in ultrasound-based transdermal delivery. The various challenges associated with sonophoretic drug delivery and trends of future research are also highlighted.
The evolution of ultrasonic contrast agents to enhance the reflectivity of structures in the human body has consolidated ultrasound's stance as a reliable diagnostic imaging modality. A significant development within this field includes the advent of liquid nanodroplets that are capable of vaporising into gaseous microbubbles upon ultrasonic irradiation. This literature review will therefore appraise and summarise the available literature on the generation of phase-shift nanodroplets, their formulations, applications, safety issues, future developments and any implications that may inhibit their clinical implementation. The main findings of this review affirm that phase change nanodroplets do indeed demonstrate functionality in drug delivery and targeting and characterisation of tumours. Its bioeffects however, have not yet been extensively researched, prompting further exploration into how bubble size can be controlled once it has vaporised into microbubbles and the resulting complications. As such, future research should be directed towards determining the safety, longevity and suitability of phase-shift nanodroplets over contrast agents in current clinical use.
Polymerization-induced self-assembly (PISA), which allows scalable synthesis of nano-objects, has drawn significant research attention in the past decade. However, the initiation methods in most of the current reported PISA are still restricted to thermal or photo processes. Sonolysis of a water molecule by high frequency ultrasound to generate a hydroxyl radical and to initiate polymerization has the potential to be a new “initiator-free” synthesis technique. Despite ultrasound-initiated polymerization-induced self-assembly (sono-PISA) being reported, only spherical micelle morphology was achieved. We demonstrate here the first room temperature synthesis of diblock copolymer nano-objects with different morphologies using ultrasound (990 kHz) initiated reversible addition–fragmentation chain transfer PISA (sono-RAFT-PISA) in an aqueous system. It was found that the morphologies of the block copolymer nano-objects prepared by sono-RAFT-PISA were different from those prepared by conventional thermal-PISA. Furthermore, the impacts of ultrasound and presence of a cross-linker on the nano-object morphology were investigated. It was observed that the stability of worm-like micelles will be affected by ultrasound but could be strengthened via core-cross-linking (CCL). Overall, the externally-regulatable, easily scalable and sustainable “green” features of ultrasound have the potential to promote the application of sono-PISA for the fabrication of nano-objects.
Ultrasound-induced cavitation has been used as a tool of enhancing extravasation and tissue penetration of anticancer agents in tumours. Initiating cavitation in tissue however, requires high acoustic intensities that are neither safe nor easy to achieve with current clinical systems. The use of cavitation nuclei can however lower the acoustic intensities required to initiate cavitation and the resulting bio-effects in situ. Microbubbles, solid gas-trapping nanoparticles, and phase shift nanodroplets are some examples in a growing list of proposed cavitation nuclei. Besides the ability to lower the cavitation threshold, stability, long circulation times, biocompatibility and biodegradability, are some of the desirable characteristics that a clinically applicable cavitation agent should possess. In this study, we present a novel formulation of ultrasound-triggered phase transition sub-micrometer sized nanodroplets (~400 nm) stabilised with a biocompatible polymer, polydopamine (PDA). PDA offers some important benefits: (1) facile fabrication, as dopamine monomers are directly polymerised on the nanodroplets, (2) high polymer biocompatibility, and (3) ease of functionalisation with other molecules such as drugs or targeting species. We demonstrate that the acoustic intensities required to initiate inertial cavitation can all be achieved with existing clinical ultrasound systems. Cell viability and haemolysis studies show that nanodroplets are biocompatible. Our results demonstrate the great potential of PDA nanodroplets as an acoustically active nanodevice, which is highly valuable for biomedical applications including drug delivery and treatment monitoring.
16 September 2021 in Journal of Materials Chemistry B
In this study, polydopamine mesoporous nanobowls stabilise photothermally responsive oil-in water Pickering emulsions. Prepared emulsions show excellent photothermal efficiency under near-infrared (NIR) illumination, offering potential in NIR triggered drug release.